Favor 3 Europe Japan Trial
FAVOR III
The trial will investigate something something computation of fractional flow reserve (FFR) based on invasive coronary angiographic images and will evaluate something of intermediate coronary stenosis.
Trial period
•
2018 - 2026
Status
•
Follow-up
Inclusions
•
2000 Complete
Centers
•
43
Countries
•
13
Publications
•
3
MEDIA
PUBLICATIONS
Repeatability and quality assessment of QFR in the FAVOR III Europe trial
Kristensen Sophie Kjerstein, Holm Marie Barbara, Maillard Luc, Råmunddal Truls, Guiducci Vincenzo, +12 more
Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study.
Kristensen Sophie Kjerstein, Holm Marie Barbara, Maillard Luc, Råmunddal Truls, Guiducci Vincenzo, +12 more
Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe)
Andersen Birgitte Krogsgaard, Sejr-Hansen Martin, Maillard Luc, Campo Gianluca, Råmunddal Truls, +29 more